Document Detail


Circulating plasma concentrations of atrial natriuretic peptide and catecholamines in response to maximal exercise in normal and asthmatic subjects.
MedLine Citation:
PMID:  1837626     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Intravenous infusion of atrial natriuretic peptide has been shown to cause bronchodilatation in patients with asthma and endogenous atrial natriuretic peptide is known to rise with exercise. Whether an aberration in release of atrial natriuretic peptide is concerned in the pathogenesis of exercise induced bronchoconstriction has not been studied. METHODS: The atrial natriuretic peptide response to exercise was studied in eight men with exercise induced asthma and eight age matched non-asthmatic men. Subjects exercised to exhaustion on a treadmill, using the Bruce protocol. Atrial natriuretic peptide and catecholamines were measured at the end of each stage of exercise and oxygen consumption and heart rate were monitored throughout. RESULTS: Both groups showed a 3.5 fold increase in plasma atrial natriuretic peptide during exercise (mean (SE): normal subjects 25 (4) pmol/l; asthmatic subjects 24 (5) pmol/l), with no difference between the two groups. There was a close correlation between plasma atrial natriuretic peptide concentrations and oxygen uptake, catecholamine release, and heart rate in both groups. The catecholamine response was similar in the asthmatic and normal subjects, both groups showing a four fold rise in plasma adrenaline and a 4-5 fold rise in plasma noradrenaline. CONCLUSION: A defect in the release of circulating atrial natriuretic peptide does not account for exercise induced asthma; the concentrations of the circulating peptide that were achieved may effect a small reduction in airway reactivity. Our data do not support the idea that asthmatic patients have abnormal sympathoadrenal activity.
Authors:
G Hulks; A F Mohammed; A G Jardine; J M Connell; N C Thomson
Related Documents :
2975706 - Exaggerated atrial natriuretic peptide release during acute exercise in essential hyper...
22486836 - Factors associated with physical activity levels in african-american women with type 2 ...
8544396 - Nitric oxide antagonizes the actions of angiotensin ii to enhance tubuloglomerular feed...
9451626 - Is urodilatin the missing link in exercise-dependent renal sodium retention?
3083486 - Role of hypocapnia in the alveolar surfactant increase induced by free fatty acid intra...
10666756 - Preserving normal ventricular activation versus atrioventricular delay optimization dur...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thorax     Volume:  46     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  1991 Nov 
Date Detail:
Created Date:  1992-02-24     Completed Date:  1992-02-24     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  824-8     Citation Subset:  IM    
Affiliation:
Department of Respiratory Medicine, Western Infirmary, Glasgow.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Asthma, Exercise-Induced / blood*
Atrial Natriuretic Factor / blood*
Epinephrine / blood*
Exercise / physiology*
Forced Expiratory Volume / physiology
Heart Rate / physiology
Humans
Male
Norepinephrine / blood*
Oxygen Consumption / physiology
Time Factors
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
51-41-2/Norepinephrine; 51-43-4/Epinephrine; 85637-73-6/Atrial Natriuretic Factor
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of idiopathic vertebral sclerosis, Zöetermeer, Rotterdam, 1975-1978.
Next Document:  Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic c...